• Regulatory Services in Switzerland

    Overview

    With a combination of public and private healthcare systems, Switzerland stands as a lucrative destination for foreign medical devices and medicine manufacturers. To ensure the high quality of the products to be imported, SWISSMEDIC – the Swiss agency for therapeutic products (medicinal products and medical devices) oversees the regulations and legal mandates in the region. Organizations have to comply with the Swiss requirements regarding product safety. But the Regulatory procedural complexities involved might challenge the manufacturers’ market entry strategies.

  • Regulatory Services in Poland

    Overview

    Situated in Central Europe, Poland stands a good access point for other regions in Europe. In addition, Poland’s steadily growing economy predominantly boasts a good fortune for foreign medicine and medical devices manufacturers for investments. However, the health sector is highly regulated and the Ministry of Health oversees the regulations regarding necessary market authorizations and market approvals. In addition, lack of profound knowledge on local regulatory rules would pose a great challenge for manufacturers to sail through the approval procedures.

  • Regulatory Services in Romania

    Overview

    With a Universal Healthcare System and a prosperous Healthcare sector, Romania shows a good fortune to invest for foreign medicine and medical device manufacturers. The market entry requires approvals from the National Agency for Medicines and Medical Devices (NAMMD), which oversees the regulations in the region. Apart from long registration lead-times, lack of knowledge on Romania’s systematic Regulatory mechanism might affect manufacturer’s efforts to get market authorizations.

  • Regulatory Services in Portugal

    Overview

    Growing economic conditions and rapidly evolving healthcare systems attract foreign medicinal product and medical device manufacturers to invest in the Portuguese Republic. However, to start with, foreign manufacturers must submit an authorization application to the national medicine regulatory authority (INFARMED), an authority responsible for the monitoring and supervision regulations in the region. Right from requiring an authorized representative from anywhere in the EU region, the language barrier might challenge foreign manufacturer’s effort to enter the region.

  • Regulatory Services in Netherlands

    Overview

    With the quality and accessibility of healthcare system, Netherlands stands a best bet for foreign manufacturers to invest in the region. The EU list of competent authorities oversees the Regulatory activities in the region. With the major reforms taken place in the Regulatory regime, getting enough ground on improved procedures for obtaining market authorizations in the region would be a great challenge for foreign manufacturers.

  • Regulatory Services in Slovakia

    Overview

    In order to enter the Slovakian Medicinal Products and Medical Devices market, foreign manufacturers must need an authorized representative from anywhere in the EU region. Manufacturers must notify the State Institute for Drug Control (SUKL) to get the market access. With the growing requirement for sophisticated health technologies and equipment in the region, Slovakia offers excellent market opportunities for foreign manufacturers.

  • Regulatory Services in Italy

    Overview

    With a mixed public-private healthcare system, Italy attracts medicinal products or device manufacturers from across the globe. At the same time, the requirement for controlled drug / device releases in the market necessitates foreign manufacturers to be more vigilant on the regulations imposed by the Ministry of Health. While Agenzia Italiana del Farmaco, AIFA - the Italian Medicines Agency - is responsible for drug regulations, medical devices are regulated by European Union’s competent authorities.

  • Regulatory Services in Belgium

    Overview

    In order to enter the Belgium region, foreign medicinal product or medical device manufacturers should need an authorized representative from anywhere in the European Union (EU). Manufacturers should notify the local regulatory body - the Federal Agency for Medicines and Health Products (FAMHP) - to get the market access. Located at the heart of the EU, Belgium can be a distribution touchpoint and offers excellent market opportunities for foreign manufacturers.

  • Regulatory Services in Croatia

    Overview

    Starting July 1, 2013, Croatia has become the official member of European Union (EU) with the Agency for Drugs and Medical Devices (HALMED) overseeing the Regulatory and compliance activities in the region pertaining to medicinal products and medical devices. Though the valuable efforts have been made to align the country’s registration requirements with that of the EU Directives, the fact that those have not yet been fully aligned might jolt the regulatory planning of new market entrants.